Use of selective inhibition of nuclear export (SINE) using a CRM1/XPO1 antagonist to overcome resistance to CPT-11 in colon cancer in preclinical models.
Hye Won Chung
No relevant relationships to disclose
Roberto A. Salas Fragomeni
No relevant relationships to disclose
Sharon Shacham
No relevant relationships to disclose
Michael Kauffman
No relevant relationships to disclose
James C. Cusack
No relevant relationships to disclose